NYSE$OSCR

Oscar Health Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Headline financials

Total Revenue

$369M

Previous: $88.1M+319.3%
EPS (adj)

-$0.98

Previous: -$10.18+90.4%
Medical loss ratio

74.4%

Previous: 81.1%-8.3%
Free Cash Flow

-$87.4M

No prior period
Net Income

-$87.4M

Previous: -$96.9M+9.8%
Operating Income

-$62.5M

Previous: -$95.9M+34.8%
Gross Profit

$111M

Previous: $123M-9.9%
Cash & Equivalents

$2.32B

Previous: $492M+372.1%
Total Assets

$3.59B

No prior period
Stock-Based Comp

$19.1M

Previous: $8.1M+136.1%

Revenue & EPS history

Oscar Health · Revenue · Quarterly

$369M

Q1 2021+319.3%vs Q1 2020
Beat estimate in 3 of 11 quarters(27%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+3.7%

Avg return

Earnings day

+5.6%

Avg return

5 days after

+7.5%

Avg return

30 days after

64%

16 / 25 earnings

Positive

+30.0%

Q1 2025

Best reaction

-23.9%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.7%+22.6%+36.6%
Q4 2025+1.7%+6.0%+2.7%
Q3 2025-2.8%-12.8%-1.5%
Q1 2025+30.0%+28.7%+18.0%
Q4 2024+3.1%-3.7%+4.5%
Q3 2024-12.9%-12.8%+0.4%
Q2 2024+7.2%+4.4%-1.4%
Q1 2024+9.3%+14.1%+2.8%
Q4 2023+22.7%+27.5%+7.7%
Q3 2023+23.5%+24.5%+42.0%
Q2 2023+8.6%+1.9%-10.5%
Q1 2023-8.8%-6.6%+17.8%
Q4 2022+21.0%+36.2%-3.9%
Q3 2022-23.9%-4.5%-11.3%
Q2 2022+19.9%+21.1%-3.7%
Q1 2022-8.9%-2.0%-25.0%
Q4 2019+6.3%+2.5%+39.1%
Q4 2021+2.4%+15.6%+21.9%
Q3 2020-2.4%-6.3%-12.7%
Q3 2021-23.3%-25.2%-33.0%
Q2 2020-16.4%-11.8%+19.4%
Q2 2021-0.9%-12.0%+17.9%
Q4 2020+15.2%+14.5%+23.1%
Q1 2020+15.2%+14.5%+23.1%
Q1 2021+3.6%+4.2%+14.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro